What we want to do is remove about 0.35 acres of current site wetlands, in exchange for wetlands that are already in place, ...

Flu vaccine makers may face a last-minute scramble to produce enough doses after an FDA advisory committee meeting was ...

A panel of scientific experts that advises the Food and Drug Administration on vaccine policy learned Wednesday that its upcoming meeting to discuss next year’s flu vaccines had been canceled.

Meanwhile, a New Drug Application (NDA) for another one of Ascentage Pharma’s key drug candidates, the novel Bcl-2 selective inhibitor lisaftoclax (APG-2575), has already been accepted and granted the ...

Integral Molecular, a leader in antibody discovery against membrane proteins, is pleased to announce that its out-licensed anti-Claudin 6 (CLDN6) bispecific antibody, CTIM-76, has been dosed in the ...

Cases in Texas and other states are on the rise, but most of the infected were not vaccinated. Here’s what to know about the ...

One committee member, Dr. Paul Offit of the Children’s Hospital of Philadelphia ... was later developed by the pharmaceutical giant Merck and approved by the F.D.A. in 2006, before Dr. Offit ...

A higher prostate cancer behavior score was associated with a 31% reduction in the hazard for all-cause mortality and a 33% ...

FMC is an American chemical manufacturing company headquartered in Philadelphia. While very off-the-radar, this Biggest Loser pays a hefty 4.22% dividend and, down 33.3%, offers solid total return ...

Ghatalia disclosed relationships with AstraZeneca, the Bristol Myers Squibb Foundation, and Merck. Grivas disclosed relationships with Gilead Sciences, Seagen, EMD Serono, Ares Trading ...